{"doi":"10.1210/jcem-43-2-453","title":"Suppression by Thyrotropin-Releasing Hormone (TRH) of Growth Hormone Release Induced by Arginine and Insulin-Induced Hypoglycemia in Man","abstract":null,"journal":"The Journal of Clinical Endocrinology & Metabolism","year":1976,"id":597171,"datarank":0.5456379239589579,"base_score":3.6375861597263857,"endowment":3.6375861597263857,"self_citation_contribution":0.5456379239589579,"citation_network_contribution":0.0,"self_endowment_contribution":0.5456379239589579,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":37,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1529837,"name":"YUZURU KATO","orcid":null,"position":1,"is_corresponding":false},{"id":180135,"name":"KAZUO CHIHARA","orcid":null,"position":2,"is_corresponding":false},{"id":1529838,"name":"SHOZO OHGO","orcid":null,"position":3,"is_corresponding":false},{"id":1529839,"name":"YOSHIKO IWASAKI","orcid":null,"position":4,"is_corresponding":false},{"id":1529840,"name":"HIROMI ABE","orcid":null,"position":5,"is_corresponding":false},{"id":1529841,"name":"ANDHIROO IMURA","orcid":null,"position":6,"is_corresponding":false},{"id":1529836,"name":"KIYOSHI MAEDA","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Suppression by Thyrotropin-Releasing Hormone (TRH) of Growth Hormone Release Induced by Arginine and Insulin-Induced Hypoglycemia in Man","abstract":"Plasma growth hormone (GH) levels were significantly increased following L-arginine (30 g) infusion or insulin (0.1 U/kg body wt)-induced hypoglycemia in normal men. When synthetic thyrotropin-releasing hormone (TRH) (1 mg) was infused intravenously for 150 min, beginning 30 min before arginine or insulin administration, GH responses to arginine and insulin were significantly blunted with a mean (+/- SE) percentage inhibition of 80.1 +/- 8.8% and 30.6 +/- 10.3%, respectively. These results suggest a possible inhibitory effect of TRH on GH secretion in man.","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"820711","pmcid":null,"openalex_id":null,"authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":null,"oa_locations":[{"url":"http://academic.oup.com/jcem/article-pdf/43/2/453/10523045/jcem0453.pdf","host_type":"publisher"}],"fields_of_study":[],"mesh_terms":["Pituitary Gland","Humans","Hypoglycemia","Insulin","Growth Hormone","Arginine","Adult","Male","Thyrotropin-Releasing Hormone"],"keywords":[],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-28T12:29:45.743153Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}